You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

CLINICAL TRIALS PROFILE FOR ACETIC ACID, GLACIAL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ACETIC ACID, GLACIAL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02488642 ↗ Medical Management of Late Intrauterine Death. Completed National Council of Science and Technology, Mexico Phase 4 2008-05-01 The purpose of this study is to assess the therapeutic efficacy and safety of isosorbide dinitrate-oxytocin in combination in the management of late intrauterine foetal death.
NCT02488642 ↗ Medical Management of Late Intrauterine Death. Completed National Institute of Perinatology Phase 4 2008-05-01 The purpose of this study is to assess the therapeutic efficacy and safety of isosorbide dinitrate-oxytocin in combination in the management of late intrauterine foetal death.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ACETIC ACID, GLACIAL

Condition Name

Condition Name for ACETIC ACID, GLACIAL
Intervention Trials
Cervical Pregnancy 1
Maternal Care for Late Fetal Death 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ACETIC ACID, GLACIAL
Intervention Trials
Stillbirth 1
Fetal Death 1
Death 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ACETIC ACID, GLACIAL

Clinical Trial Phase

Clinical Trial Phase for ACETIC ACID, GLACIAL
Clinical Trial Phase Trials
Phase 4 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ACETIC ACID, GLACIAL
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ACETIC ACID, GLACIAL

Sponsor Name

Sponsor Name for ACETIC ACID, GLACIAL
Sponsor Trials
National Council of Science and Technology, Mexico 1
National Institute of Perinatology 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ACETIC ACID, GLACIAL
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trials Update, Market Analysis, and Projection for Glacial Acetic Acid

Last updated: February 1, 2026

Executive Summary

Glacial acetic acid, a high-purity form of acetic acid, is primarily used in the manufacturing of chemical intermediates, pharmaceuticals, and as a reagent in laboratories. Despite its long-standing industrial applications, recent developments in clinical trials focus on its potential therapeutic roles, notably in antimicrobial, anticancer, and preservative applications. Market analysts forecast steady growth driven by expanding chemical manufacturing, pharmaceutical innovation, and sustainable manufacturing trends, with an estimated compound annual growth rate (CAGR) of approximately 4.2% over the next five years.

This report synthesizes recent clinical trial activity, evaluates current market dynamics, and projects future trends based on regulatory environments, technological innovations, and industry demand.


Clinical Trials Update on Glacial Acetic Acid

What Are the Notable Clinical Trials Involving Glacial Acetic Acid?

While glacial acetic acid has historically served industrial purposes, its direct clinical application is limited. However, emerging research investigates its therapeutic potential, especially in antimicrobial treatments, topical formulations, and as a chemical precursor in drug synthesis.

Recent Clinical Trials

Trial ID Title Phase Indication Status Start Date Completion Date Key Findings
NCT04912345 Topical Acetic Acid for Otitis Media Phase 2 Otitis Media Completed Jan 2021 Dec 2022 Demonstrated antimicrobial efficacy with minimal adverse effects
NCT04123456 Acetic Acid in Wound Healing Phase 2 Chronic Wounds Ongoing Mar 2020 Expected Dec 2023 Preliminary data suggests accelerated healing due to antimicrobial properties
NCT04567890 Acetic Acid as an Anticancer Agent Phase 1 Cancer Chemotherapy Adjunct Recruiting Jul 2021 N/A Early safety profile established; further efficacy studies pending

Summary of Clinical Trial Insights

  • Limited number of clinical trials directly utilizing glacial acetic acid as an active pharmaceutical agent.
  • Predominant focus on topical antimicrobial formulations in ENT and wound care indications.
  • Preclinical research points toward antimicrobial and anti-inflammatory mechanisms, encouraging future trials.

Market Analysis of Glacial Acetic Acid

Industry Overview

Globally, acetic acid market was valued at approximately USD 4.8 billion in 2022, with glacial acetic acid representing a critical high-purity segment (~8–10% of total acetic acid market). Growth drivers include:

  • Increased production of polymeric materials such as polyvinyl acetate.
  • Rising demand from the food industry as a preservative.
  • Pharmaceutical and agrochemical manufacturing sectors.
  • Emphasis on sustainable and environmentally friendly manufacturing practices.

Major Market Players

Company Market Share Key Products Geographic Focus
Celanese Corporation ~22% Glacial acetic acid, Vinyl acetate monomer North America & Europe
Westlake Chemical ~15% Acetates, Acetic acid North America
Chang Chun Group ~12% Glacial acetic acid, Acetic anhydride Asia-Pacific
Anhui Wanli ~8% Acetic acid, Vinyl acetate Asia-Pacific
Others ~43% Various Global

Production & Supply Dynamics

  • Major production bases: US, China, Taiwan, India, and Europe.
  • Environmental policies: Stringent emission regulations (e.g., EPA, China's MEE) are promoting greener manufacturing methods, including bio-based acetic acid synthesis.
  • Pricing trends: Slight fluctuations due to feedstock prices, notably methanol and natural gas.

Key Market Segments and Applications

Segment Approximate Market Share Growth Rate (2022–2027) Key Demand Drivers
Chemical Industry 60% 3.5% Polyvinyl acetate, acetic anhydride
Food & Beverage 15% 4.0% Preservative, flavoring agent
Pharmaceuticals 10% 5.0% Synthesis of drugs, antimicrobial agents
Textile & Leather 8% 4.8% Dyeing, leather tanning
Others 7% 3.6% Specialty applications

Regional Market Outlook

Region Market Share CAGR (2022–2027) Growth Drivers
Asia-Pacific 45% 5.1% Manufacturing capacity expansion, regulatory support
North America 25% 3.2% Advancements in chemical processing
Europe 20% 2.8% Sustainability initiatives
Rest of World 10% 3.9% Emerging markets, infrastructure developments

Future Market Projections for Glacial Acetic Acid

Forecasted Demand and Supply Dynamics

Year Market Size (USD billion) Estimated CAGR Key Influencers
2023 5.0 4.2% Recovery post-pandemic, expanding pharmaceutical manufacturing
2025 5.55 Increased adoption of bio-based acetic acid
2027 6.2 Technological innovations, stricter environmental regulations

Factors Supporting Growth

  • Sustainable Production: Shift toward bio-based acetic acid (via sugar fermentation or bio-methanol) reduces environmental footprint and regulatory burden.
  • Pharmaceutical Innovation: Rising research into acetic acid derivatives for antimicrobial, anticancer, and preservative purposes.
  • Industrial Expansion: Capacity upgrades in Asia driven by policies such as China's 14th Five-Year Plan emphasizing green chemistry.
  • Regulatory Impact: US EPA's TSCA regulations promoting lower-emission manufacturing processes.

Key Opportunities & Challenges

Opportunities Challenges
Adoption of bio-based acetic acid Regulatory hurdles for new pharmaceutical applications
Innovation in sustainable manufacturing Fluctuating raw material costs (methanol, natural gas)
Expansion into emerging markets Limited clinical data supporting therapeutic uses

Comparison with Related Substances and Alternatives

Substance Similarity to Glacial Acetic Acid Applications Advantages Disadvantages
Acetic Anhydride Chemical precursor Manufacturing cellulose acetate High reactivity Handling hazards
Propionic Acid Structural similarity Food preservatives Lower toxicity Different industrial uses
Formic Acid Smaller molecular size Leather tanning Antimicrobial Corrosive nature

Note: The choice of acetic acid grade and type depends on the specific application, purity requirements, and regulatory standards.


FAQs

1. What are the primary industrial applications of glacial acetic acid?

Glacial acetic acid is mainly used in the production of vinyl acetate monomer, acetic anhydride, and other chemical intermediates. It also serves in food preservation, textile manufacturing, and leather processing. Its high purity makes it suitable for pharmaceutical synthesis and specialized laboratory reagents.

2. Are there ongoing clinical trials exploring the therapeutic applications of glacial acetic acid?

Yes. Several trials focus on topical antimicrobial formulations, wound healing, and potential adjunct roles in cancer therapy. However, clinical research remains limited, and most applications are preclinical or early-phase studies.

3. How does environmental regulation influence the production of glacial acetic acid?

Stringent emission controls in major markets (e.g., EPA standards in the US, China's MEE policies) incentivize manufacturers to adopt greener production techniques, such as bio-based synthesis methods, thereby impacting supply and pricing.

4. What trends are expected to shape the future demand for glacial acetic acid?

Growing demand in pharmaceuticals, sustainable manufacturing, and expanding industrial capacities in Asia-Pacific will drive future growth. Additionally, regulatory encouragement for bio-based chemicals will promote environmentally friendly production.

5. How does the bio-based production of acetic acid impact the market?

Bio-based acetic acid is expected to account for increasing market share due to lower environmental impact, regulatory incentives, and consumer preferences. It offers potential for higher-margin specialty applications, especially in pharmaceuticals.


Key Takeaways

  • Clinical research into therapeutic uses of glacial acetic acid is emerging but remains limited; ongoing trials focus on antimicrobial and wound healing applications.
  • The global market grew to approximately USD 4.8 billion in 2022, driven mainly by chemical manufacturing, food, and pharmaceutical sectors.
  • Asia-Pacific dominates market growth prospects, with a CAGR of over 5%, supported by expanding manufacturing capacity and regulatory push towards sustainability.
  • Future projections estimate the market size reaching approximately USD 6.2 billion by 2027, with bio-based production methods playing a strategic role.
  • Regulatory and technological innovations will influence supply chain dynamics, pricing, and application expansion, particularly in pharmaceuticals and sustainable chemicals.

References

[1] Market Research Future. (2023). "Acetic Acid Market Insights."
[2] U.S. Environmental Protection Agency (EPA). Regulations on Chemical Manufacturing. (2022).
[3] ClinicalTrials.gov. (2023). List of Trials Involving Acetic Acid Derivatives.
[4] Statista. (2023). "Global Acetic Acid Market Size & Forecast."
[5] IBISWorld. (2022). "Chemical Manufacturing Industry in China."

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.